Bid to delay three-week AFT Pharmaceuticals trial declined

Bid to delay three-week AFT Pharmaceuticals trial declined
AFT Pharmaceuticals' managing director Hartley Atkinson is claiming PBL Solutions is taking against the NZX-listed company. (Image: Supplied)
Riley Kennedy
AFT Pharmaceuticals will face off against a former joint venture partner after the high court rejected a bid to delay the dispute's hearing until 2024.In the high court at Auckland, Justice Geoffrey Venning affirmed a three-week hearing between AFT and British Virgin Islands-based PBL Solutions will take place in October this year, bringing their two-year-old dispute to a head. PBL sought to have the case pushed out by 12 months, although the courts wouldn't have been able to hear it before 2024.While the judge rejected the applica...

More Markets

NZ sharemaket up 0.1% despite 'volatile' markets
Markets Market Close

NZ sharemaket up 0.1% despite 'volatile' markets

The S&P/NZX 50 Index closed at 12,338.57, up 18.38 points or 0.15%.

Graham Skellern 03 Apr 2025
NZX-listed companies take stock in wake of US tariff moves
Economy

NZX-listed companies take stock in wake of US tariff moves

Wine makers, manufacturers and others mull what trade wars will bring.

Ian Llewellyn 03 Apr 2025
Analysts struggle to find upside from Trump tariffs
Economy

Analysts struggle to find upside from Trump tariffs

‘They've forgotten the lessons of the Great Depression,’ one analyst said.

Gregor Thompson 03 Apr 2025
S&P/ASX200 takes a tumble on Trump's Liberation Day, Asia to follow suit
Markets

S&P/ASX200 takes a tumble on Trump's Liberation Day, Asia to follow suit

The fall may be short lived now there is more certainty. 

Rebecca Howard 03 Apr 2025